Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting-Reference-Cited by-同舟云学术

Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting

Author:

Strober Bruce¹²^ORCID,Patil Dhaval³,McLean Robert R.⁴,Moore-Clingenpeel Melissa⁵,Guo Ning⁵,Levi Eugenia⁶,Lebwohl Mark⁷

Affiliation:

1. Department of Dermatology, Yale University, New Haven, CT, USA

2. Department of Dermatology, Central Connecticut Dermatology Research, Cromwell, CT, USA

3. Department of Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

4. Department of Epidemiology, CorEvitas, LLC, Waltham, MA, USA

5. Department of Biostatistics, CorEvitas, LLC, Waltham, MA, USA

6. Department of Dermatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

7. Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Publisher

Informa UK Limited

Subject

Dermatology

Link

Reference35 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献